The T-peak–T-end Interval as a Marker of Repolarization Abnormality: A Comparison with the QT Interval for Five Different Drugs

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The T-peak–T-end Interval as a Marker of Repolarization Abnormality : A Comparison with the QT Interval for Five Different Drugs. / Bhuiyan, Tanveer A.; Graff, Claus; Kanters, Jørgen K.; Nielsen, Jimmi; Melgaard, Jacob; Matz, Jørgen; Toft, Egon; Struijk, Johannes J.

I: Clinical Drug Investigation, Bind 35, Nr. 11, 11.2015, s. 717-724.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bhuiyan, TA, Graff, C, Kanters, JK, Nielsen, J, Melgaard, J, Matz, J, Toft, E & Struijk, JJ 2015, 'The T-peak–T-end Interval as a Marker of Repolarization Abnormality: A Comparison with the QT Interval for Five Different Drugs', Clinical Drug Investigation, bind 35, nr. 11, s. 717-724. https://doi.org/10.1007/s40261-015-0328-0

APA

Bhuiyan, T. A., Graff, C., Kanters, J. K., Nielsen, J., Melgaard, J., Matz, J., Toft, E., & Struijk, J. J. (2015). The T-peak–T-end Interval as a Marker of Repolarization Abnormality: A Comparison with the QT Interval for Five Different Drugs. Clinical Drug Investigation, 35(11), 717-724. https://doi.org/10.1007/s40261-015-0328-0

Vancouver

Bhuiyan TA, Graff C, Kanters JK, Nielsen J, Melgaard J, Matz J o.a. The T-peak–T-end Interval as a Marker of Repolarization Abnormality: A Comparison with the QT Interval for Five Different Drugs. Clinical Drug Investigation. 2015 nov.;35(11):717-724. https://doi.org/10.1007/s40261-015-0328-0

Author

Bhuiyan, Tanveer A. ; Graff, Claus ; Kanters, Jørgen K. ; Nielsen, Jimmi ; Melgaard, Jacob ; Matz, Jørgen ; Toft, Egon ; Struijk, Johannes J. / The T-peak–T-end Interval as a Marker of Repolarization Abnormality : A Comparison with the QT Interval for Five Different Drugs. I: Clinical Drug Investigation. 2015 ; Bind 35, Nr. 11. s. 717-724.

Bibtex

@article{9d5c499f8cc946a68d0e735c414670e6,
title = "The T-peak–T-end Interval as a Marker of Repolarization Abnormality: A Comparison with the QT Interval for Five Different Drugs",
abstract = "BACKGROUND AND OBJECTIVE: The T-peak to T-end (TpTe) interval has been suggested as an index of transmural dispersion and as a marker of drug-induced abnormal repolarization. In this study, we investigate the relation between TpTe and the QT interval.METHODS: Electrocardiograms (ECGs) from five different drugs (sotalol, sertindole, moxifloxacin, nalmefene, and Lu 38-135) and from a placebo group were analyzed. Semi-automatic measurements of T-peak, T-end, and QRS onset were obtained. The TpTe/QT ratio was calculated to investigate the proportional relationship of QT and TpTe.RESULTS: Although a significant increase of both TpTe and QT from baseline is apparent with QT-prolonging drugs, the TpTe/QT ratio remained the same at baseline and after drug administration, thus indicating that prolongation of TpTe is just a fractional part of total QT prolongation. In the presence of notched or flattened T-waves, the uncertainty associated with measurement of the TpTe interval increases. The errors in TpTe for individual subjects may be substantial, thus complicating the use of TpTe for follow-up of individuals.CONCLUSIONS: The duration of the QT interval and TpTe are closely related. Drugs appear to prolong the TpTe interval as a predictable fraction of the total QT prolongation.",
author = "Bhuiyan, {Tanveer A.} and Claus Graff and Kanters, {J{\o}rgen K.} and Jimmi Nielsen and Jacob Melgaard and J{\o}rgen Matz and Egon Toft and Struijk, {Johannes J.}",
year = "2015",
month = nov,
doi = "10.1007/s40261-015-0328-0",
language = "English",
volume = "35",
pages = "717--724",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "11",

}

RIS

TY - JOUR

T1 - The T-peak–T-end Interval as a Marker of Repolarization Abnormality

T2 - A Comparison with the QT Interval for Five Different Drugs

AU - Bhuiyan, Tanveer A.

AU - Graff, Claus

AU - Kanters, Jørgen K.

AU - Nielsen, Jimmi

AU - Melgaard, Jacob

AU - Matz, Jørgen

AU - Toft, Egon

AU - Struijk, Johannes J.

PY - 2015/11

Y1 - 2015/11

N2 - BACKGROUND AND OBJECTIVE: The T-peak to T-end (TpTe) interval has been suggested as an index of transmural dispersion and as a marker of drug-induced abnormal repolarization. In this study, we investigate the relation between TpTe and the QT interval.METHODS: Electrocardiograms (ECGs) from five different drugs (sotalol, sertindole, moxifloxacin, nalmefene, and Lu 38-135) and from a placebo group were analyzed. Semi-automatic measurements of T-peak, T-end, and QRS onset were obtained. The TpTe/QT ratio was calculated to investigate the proportional relationship of QT and TpTe.RESULTS: Although a significant increase of both TpTe and QT from baseline is apparent with QT-prolonging drugs, the TpTe/QT ratio remained the same at baseline and after drug administration, thus indicating that prolongation of TpTe is just a fractional part of total QT prolongation. In the presence of notched or flattened T-waves, the uncertainty associated with measurement of the TpTe interval increases. The errors in TpTe for individual subjects may be substantial, thus complicating the use of TpTe for follow-up of individuals.CONCLUSIONS: The duration of the QT interval and TpTe are closely related. Drugs appear to prolong the TpTe interval as a predictable fraction of the total QT prolongation.

AB - BACKGROUND AND OBJECTIVE: The T-peak to T-end (TpTe) interval has been suggested as an index of transmural dispersion and as a marker of drug-induced abnormal repolarization. In this study, we investigate the relation between TpTe and the QT interval.METHODS: Electrocardiograms (ECGs) from five different drugs (sotalol, sertindole, moxifloxacin, nalmefene, and Lu 38-135) and from a placebo group were analyzed. Semi-automatic measurements of T-peak, T-end, and QRS onset were obtained. The TpTe/QT ratio was calculated to investigate the proportional relationship of QT and TpTe.RESULTS: Although a significant increase of both TpTe and QT from baseline is apparent with QT-prolonging drugs, the TpTe/QT ratio remained the same at baseline and after drug administration, thus indicating that prolongation of TpTe is just a fractional part of total QT prolongation. In the presence of notched or flattened T-waves, the uncertainty associated with measurement of the TpTe interval increases. The errors in TpTe for individual subjects may be substantial, thus complicating the use of TpTe for follow-up of individuals.CONCLUSIONS: The duration of the QT interval and TpTe are closely related. Drugs appear to prolong the TpTe interval as a predictable fraction of the total QT prolongation.

U2 - 10.1007/s40261-015-0328-0

DO - 10.1007/s40261-015-0328-0

M3 - Journal article

C2 - 26410545

VL - 35

SP - 717

EP - 724

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 11

ER -

ID: 160775144